2007 Fiscal Year Final Research Report Summary
Improvement of Treatment for Urological Cancer by controlling Function of Apotosis-associated molecules using siRNA.
Project/Area Number |
17390435
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Urology
|
Research Institution | Yamagata University |
Principal Investigator |
TOMITA Yoshihiko Yamagata University, Faculty of Medicine, Department of Urology, Professor and Chairman (90237123)
|
Co-Investigator(Kenkyū-buntansha) |
KATO Tomoyuki Yamagata University, Faculty of Med Dpt of Urology, assistant professor (40396560)
VLADIMIR Bilim Yamagata University, Faculty of Med Dpt of Urology, junior professor (50334686)
MUTO Akinori Yamagata University, Faculty of Med Dpt of Urology, junior professor (00282228)
|
Project Period (FY) |
2005 – 2007
|
Keywords | siRNA / Uroloeical Cancer / Anontosis / renal cell cancer / prostate cancer / XIAP / Bcl-2 |
Research Abstract |
1. XIAP knock down by siRNA or shRNA. Designed and introduction of XIAP siRNA or shRNA, decreased production of XIAP transiently or continuously, respectively. 2. Prostate cancer model using DU145 (1) Sensitivity to anticancer drug and knock down of XIAP expression. Transient suppression of XIAP resulted in increase susceptibility to CDDP, but continuous suppression induced resistant character than parent cell. Upregulation of BCL-2 and NF κ-B were observed in stable transfectants. (2) Restore the sensitivity by anti-BCL-2 small molecule HA14-1. HA14-1 cancelled decrease the susceptibility to CDDP. 3. Renal cell cancer model using Caki-1. (1) XIAP and smac expression in normal kidney and renal cell cancer (RCC). In normal kidney, smac and XIAP were expressed in renal tubular cells. In 34 RCCs, smac was expressed less frequently, XIAP was strongly expressed in high grade and stage tumor. XIAP and smac were highly expressed in Caki-I and KRC/Y, respectively. (2) Effect of HA14-1 or smac-mimic synthetic peptide (smac-ant) on cell growth in Caki-1 XIAP lower expresser clone. HA14-1 alone revealed modest suppression of cell growth but combination with anti-Fas antibody resulted in additional effect-CDDP and smac-ant treatment showed high suppression. 4. In conclusion, XIAP seems to decrease susceptibility to apoptotic stimuli in prostate and renal cell cancer. Suppression using shRNA may not be enough to overcome such character, and additional treatment for reduction of BCL-2 function or further suppression of XIAP using smac-ant might be useful.
|
Research Products
(26 results)
-
[Journal Article] Molecular targeting of BCL-2 overcomes prostate cancer cell adaptation to XIAP gene downregulation.2008
Author(s)
Yuko, Nakano, Vladimir, Bilim, Kaori, Yuuki, Akinori, Muto, Tomoyuki, Kato, Akira, Nagaoka, Yoshihiko, Tomita
-
Journal Title
Prostate Cancer and Prostatic Disease (In press)
Description
「研究成果報告書概要(和文)」より
Peer Reviewed
-
[Journal Article] Double inhibition of XIAP and Bcl-2 axis is beneficial for retrieving sensitivity of renal cell cancer to apoptosis.2008
Author(s)
Bilim, V, Yuuki, K, Itoi, T, Muto, A, Kato, T, Nagaoka, A, Motoyama, T, Tomita, Y.
-
Journal Title
Br. J. Cancer 98
Pages: 941-9
Description
「研究成果報告書概要(和文)」より
Peer Reviewed
-
-
-
[Presentation] Inhibition of GSK-3B activity suppresses the proliferation and induces apoptosis in bladder cancer2008
Author(s)
Sei Naito, Bilim Vladimir, Kaori Suzue, Akinori Muto, Akira Kajinuma, Yuko Kawamura, Hisashi Kawazoe, Tomohiro Shibazaki, Tomoyuki Kato, Akira Nagaoka, Yoshihiko Tomita
Organizer
America Urological Association Annual Meeting 2008 Anaheim(cont'd)
Place of Presentation
Anaheim, USA
Year and Date
2008-05-19
Description
「研究成果報告書概要(欧文)」より
-
[Presentation] The Smac-N7 cell permeable peptide sensitizes renal cancer cells to anti-cancer drug Cisplatin2008
Author(s)
Tomoyuki Kato, Bilim Vladimir, Kaori Suzue, Akinori Muto, Akira Kajinuma, Yuko Kawamura, Hisashi Kawazoe, Tomohiro Shibazaki, Sei Naito, Akira Nagaoka, Yoshihiko Tomita
Organizer
America Urological Association Annual Meeting 2008
Place of Presentation
Anaheim, USA
Year and Date
2008-05-18
Description
「研究成果報告書概要(欧文)」より
-
-
-
[Presentation] Multiple targeting of anti-apoptotic molecules can induce apoptosis in RCC2008
Author(s)
Kaori, Yuuki, Vladimir, Bilim, Tomohiro, Shibazaki, Hisashi, Kawazoe, Teiichi, Motoyama, Yoshihiko Tomita
Organizer
第17回泌尿器科分子・細胞研究会
Place of Presentation
東京
Year and Date
2008-02-16
Description
「研究成果報告書概要(和文)」より
-
[Presentation] Inbibition of GSK3beta is a potential target to induce apoptosis in Renal Cell Catcinoma(RCC)2008
Author(s)
Vladimir, Bilim, Kaori, Yuuki, Tomohiro, Shibazaki, Hisashi Kawazoe, Teiichi, Motoyama, Yoshihiko, Tomita
Organizer
第17回泌尿器科分子・細胞研究会
Place of Presentation
東京
Year and Date
2008-02-16
Description
「研究成果報告書概要(和文)」より
-
-
-
-
[Presentation] Constitutive suppression of XIAP in DU145 prostate carcinoma cell line leads to resistance to Cisplatinum by upregulation of Bcl-22007
Author(s)
Yuko Nakano, Vladimir Bilim, Kaori Yuuki, Akinori Muto, Akira Kajinuma, Hisashi Kawazoe, Tomohiro Shibazaki, Sei Naito, Tomoyuki Kato, Akira Nagaoka, Yoshihiko Tomita
Organizer
ditto
Place of Presentation
Kyoto
Year and Date
2007-10-25
Description
「研究成果報告書概要(欧文)」より
-
-
[Presentation] SMAC-N7 PEPTIDE WAS MORE POTENT THAN XIAP GENE TARGETING IN SENSITIZING RENAL CANCER CELLS TO APOPTOTIC STIMULI2007
Author(s)
Tomoyuki Kato, Vladimir Bilim, Kaori Yuuki, Akinori Muto, Akira Kajinuma, Yuko Nakano, Hisashi Kawazoe, Tomohiro Shibazaki, Sei Naito, Akira Nagaoka, Yoshihiko Tomita
Organizer
45th Japan society of clinical oncology annual meeting
Place of Presentation
Kyoto
Year and Date
2007-10-24
Description
「研究成果報告書概要(欧文)」より
-
[Presentation] Inbibition of GSK-3beta Activity Induces Apoptosis in Renal Cell Cancer2007
Author(s)
Vladimir, Bilim, Kaori, Yuuki, AndreiV., Ougolkov, Daniel, D, Billadeau, Yoshihiko, Tomita
Organizer
第66回日本癌学会2007
Place of Presentation
横浜
Year and Date
2007-10-04
Description
「研究成果報告書概要(和文)」より
-
-
-
-
-
-
[Presentation] The Smac-N7 cell permeable peptide sensitizes renal cancercells to Cisplatin2007
Author(s)
Vladimir, Bilim, Tomoyuki, Kato, Kaori, Yuuki, Toshiyuki, Itoi, Akinori, Muto, Akira, Kajinuma, Yuko, Nakano, Hisashi, Kawazoe, Tomohiro, Shibasaki, Sei, Nito, Akira, Nagaoka, Yoshihiko, Tomita
Organizer
第95回日本泌尿器科学会総会2007
Place of Presentation
神戸
Year and Date
2007-04-15
Description
「研究成果報告書概要(和文)」より
-
-
[Presentation] The Smac-N7 cell permeable peptide sensitizes renal cancer cells to Cisplatin2007
Author(s)
Vladimir Bilim,Tomoyuki Kato,Kaori Yuuki,Toshiyuki Itoi,Akinori Muto,Akira Kajinuma,Yuko Nakano,Hisashi Kawazoe,Tomohiro Shibasaki,Sei Nito,Akira Nagaoka,Yoshihiko Tomita
Organizer
95th Japanese Urological association annual meeting
Place of Presentation
Kobe
Year and Date
2007-04-15
Description
「研究成果報告書概要(欧文)」より
-
[Presentation] Constitutive Suppression of XIAP in DU145 Prostte Carcinoma Cell Line Leads to Resistance to Cisplatinum by Upregulation of Bcl-22007
Author(s)
Yuko Kawamura, Vladimir Bilim, Kaori Yuuki, Akinori Muto, Akira Kajinuma, Hisashi Kawazoe, Tomohiro Shibazaki, Sei Naito, Tomoyuki Kato, Ak ra Nagaoka, Yoshihiko Tomita
Organizer
95th Japanese Urological association annual meeting
Place of Presentation
Kobe
Year and Date
2007-04-15
Description
「研究成果報告書概要(欧文)」より